Literature DB >> 15917855

History of weight and obesity through life and risk of benign prostatic hyperplasia.

A Zucchetto1, A Tavani, L Dal Maso, S Gallus, E Negri, R Talamini, S Franceschi, M Montella, C La Vecchia.   

Abstract

OBJECTIVE: The relation of anthropometric measures, diabetes, hypertension and hyperlipidemia with benign prostatic hyperplasia (BPH) risk was investigated.
DESIGN: Hospital-based case-control study.
SUBJECTS: Cases were 1369 men with histologically confirmed BPH, and controls were 1451 men below 75 y, admitted to hospital for acute non-neoplastic diseases. MEASUREMENTS: Using a structured questionnaire, trained interviewers collected information on self-reported height and weight, and measured waist and hip circumference of patients. The odds ratios (OR) and 95% confidence intervals (CI) were estimated using unconditional multiple logistic regression models.
RESULTS: Compared to the corresponding lowest quartile, the OR for the highest one were 0.76 (95% CI 0.59-0.98) for body weight, 0.71 (95% CI 0.54-0.94) for waist-to-hip ratio and 0.87 (95% CI 0.70-1.09) for body mass index (BMI, kg/m(2)). Compared to a lowest lifelong BMI <20.7 kg/m(2), the OR was 1.56 (95% CI 1.25-1.95) for a lowest lifelong BMI > or =23.7 kg/m(2). The OR was 0.74 (95% CI 0.60-0.93) for a lifelong increase of BMI > or =6.1 kg/m(2), compared to <1.6 kg/m(2). No association emerged for history of diabetes, hypertension and hyperlipidemia.
CONCLUSIONS: Overweight was modestly, inversely related to BPH. The hypothesis of reduced testosterone levels in obese individuals may explain the different BPH risk and need to be tested.

Entities:  

Mesh:

Year:  2005        PMID: 15917855     DOI: 10.1038/sj.ijo.0802979

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  13 in total

Review 1.  Benign prostatic hyperplasia. Part 1--diagnosis.

Authors:  Timothy J Wilt; James N'Dow
Journal:  BMJ       Date:  2008-01-19

2.  Obesity, physical activity and lower urinary tract symptoms: results from the Southern Community Cohort Study.

Authors:  David F Penson; Heather M Munro; Lisa B Signorello; William J Blot; Jay H Fowke
Journal:  J Urol       Date:  2011-10-20       Impact factor: 7.450

Review 3.  PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.

Authors:  Ming Jiang; Douglas W Strand; Omar E Franco; Peter E Clark; Simon W Hayward
Journal:  Differentiation       Date:  2011-06-08       Impact factor: 3.880

4.  Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study.

Authors:  J Kellogg Parsons; Karen Messer; Martha White; Elizabeth Barrett-Connor; Douglas C Bauer; Lynn M Marshall
Journal:  Eur Urol       Date:  2011-07-23       Impact factor: 20.096

Review 5.  Diabetes and benign prostatic hyperplasia: emerging clinical connections.

Authors:  Aruna V Sarma; J Kellogg Parsons
Journal:  Curr Urol Rep       Date:  2009-07       Impact factor: 3.092

6.  Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men.

Authors:  J Kellogg Parsons; Jaclyn Bergstrom; Elizabeth Barrett-Connor
Journal:  BJU Int       Date:  2007-11-13       Impact factor: 5.588

7.  Metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention.

Authors:  Firas Abdollah; Alberto Briganti; Nazareno Suardi; Fabio Castiglione; Andrea Gallina; Umberto Capitanio; Francesco Montorsi
Journal:  Korean J Urol       Date:  2011-08-22

Review 8.  Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions.

Authors:  Giovanni Corona; Linda Vignozzi; Giulia Rastrelli; Francesco Lotti; Sarah Cipriani; Mario Maggi
Journal:  Int J Endocrinol       Date:  2014-02-13       Impact factor: 3.257

9.  Can metabolic disorders in aging men contribute to prostatic hyperplasia eligible for transurethral resection of the prostate (TURP)?

Authors:  Aleksandra Rył; Iwona Rotter; Marcin Słojewski; Adriana Jędrzychowska; Zuzanna Marcinowska; Marta Grabowska; Maria Laszczyńska
Journal:  Int J Environ Res Public Health       Date:  2015-03-19       Impact factor: 3.390

10.  Linking pre-diabetes with benign prostate hyperplasia. IGFBP-3: a conductor of benign prostate hyperplasia development orchestra?

Authors:  Ioannis Protopsaltis; Achilles Ploumidis; Theodoros N Sergentanis; Padelis Constantoulakis; Kostantinos Tzirogiannis; Chrysoula Kyprianidou; Athanasia K Papazafiropoulou; Andreas Melidonis; Dimitrios Delakas
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.